Pharvaris N.V.
PHVS
$23.12
-$0.23-0.99%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 12.22M | 11.86M | 14.81M | 13.32M | 12.18M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 45.82M | 44.39M | 48.07M | 41.67M | 37.01M |
Operating Income | -45.82M | -44.39M | -48.07M | -41.67M | -37.01M |
Income Before Tax | -51.39M | -48.45M | -35.73M | -45.60M | -31.92M |
Income Tax Expenses | 230.10K | 318.50K | 1.32M | 253.00K | 76.00K |
Earnings from Continuing Operations | -51.62M | -48.77M | -37.05M | -45.86M | -32.00M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -51.62M | -48.77M | -37.05M | -45.86M | -32.00M |
EBIT | -45.82M | -44.39M | -48.07M | -41.67M | -37.01M |
EBITDA | -45.77M | -44.35M | -48.03M | -41.65M | -36.93M |
EPS Basic | -0.94 | -0.90 | -0.68 | -0.85 | -0.59 |
Normalized Basic EPS | -0.59 | -0.56 | -0.41 | -0.53 | -0.37 |
EPS Diluted | -0.94 | -0.90 | -0.68 | -0.85 | -0.59 |
Normalized Diluted EPS | -0.59 | -0.56 | -0.41 | -0.53 | -0.37 |
Average Basic Shares Outstanding | 54.69M | 54.49M | 54.32M | 54.07M | 53.94M |
Average Diluted Shares Outstanding | 54.69M | 54.49M | 54.32M | 54.07M | 53.94M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |